140 related articles for article (PubMed ID: 35216711)
1. Testosterone Treatment and the Risk of Prostate Adverse Events.
Levy JA; Burnett AL; Dobs AS
Endocrinol Metab Clin North Am; 2022 Mar; 51(1):123-131. PubMed ID: 35216711
[TBL] [Abstract][Full Text] [Related]
2. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
3. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy in the ageing male: what about the prostate?
Schultheiss D; Machtens S; Jonas U
Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and the Prostate: Artifacts and Truths.
DeLay KJ; Kohler TS
Urol Clin North Am; 2016 Aug; 43(3):405-12. PubMed ID: 27476133
[TBL] [Abstract][Full Text] [Related]
6. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy.
Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM
J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967
[TBL] [Abstract][Full Text] [Related]
7. Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?
Baas W; Köhler TS
Curr Urol Rep; 2016 Jun; 17(6):46. PubMed ID: 27068735
[TBL] [Abstract][Full Text] [Related]
8. Late-onset hypogonadism: Prostate safety.
Miranda EP; Torres LO
Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
[TBL] [Abstract][Full Text] [Related]
9. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
Park SG; Yeo JK; Cho DY; Park MG
Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
[TBL] [Abstract][Full Text] [Related]
10. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
11. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
[TBL] [Abstract][Full Text] [Related]
12. The role of testosterone in men's health: is it time for a new approach?
Diokno AC
Int Urol Nephrol; 2022 Nov; 54(11):2767-2774. PubMed ID: 35909146
[TBL] [Abstract][Full Text] [Related]
13. Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: a prospective study.
Shigehara K; Koh E; Sakamoto J; Yaegashi H; Izumi K; Ueno S; Kitagawa Y; Maeda Y; Kadono Y; Konaka H; Mizokami A; Nakashima T; Namiki M
Aging Male; 2014 Mar; 17(1):51-6. PubMed ID: 24134649
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update].
Kong B; Hou X; Yang JY
Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720
[TBL] [Abstract][Full Text] [Related]
15. Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms.
Li J; Tian Y; Guo S; Gu H; Yuan Q; Xie X
PLoS One; 2018; 13(1):e0191469. PubMed ID: 29351556
[TBL] [Abstract][Full Text] [Related]
16. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
Martov AG; Ergakov DV
Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
[TBL] [Abstract][Full Text] [Related]
17. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
Nicholson TM; Ricke WA
Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
[TBL] [Abstract][Full Text] [Related]
18. Periprostatic fat thickness measured on MRI correlates with lower urinary tract symptoms, erectile function, and benign prostatic hyperplasia progression.
Zhang B; Chen X; Liu YH; Gan Y; Liu PH; Chen Z; Xia WP; Dai GY; Ru F; Jiang ZX; He Y
Asian J Androl; 2021; 23(1):80-84. PubMed ID: 32859870
[TBL] [Abstract][Full Text] [Related]
19. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
[TBL] [Abstract][Full Text] [Related]
20. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
